25/02/2026
From April 2026, GP practices in England will be financially incentivised to prescribe weight-loss drugs.
These medications may be helpful and appropriate for some people. But when prescribing is tied to financial targets, it raises important ethical and psychological questions.
Weight stigma already affects the quality of care people receive. When smaller bodies become an incentivised outcome, it risks reinforcing the idea that body size is the primary marker of health or worth.
Healthcare should be grounded in dignity, informed consent, and evidence-based care, where the individual, not their weight, is at the centre.
This conversation isn’t about being for or against medication. It’s about protecting ethical care and challenging the assumption that smaller is always better.
What are your thoughts?